Table 1 Patient characteristics
Clinicopathological factors (N = 56) | N (%) |
|---|---|
T status | Â |
   1 | 28 (50%) |
   2 | 18 (32%) |
   3 | 7 (13%) |
   4 | 3 (5%) |
Nodal involvement | Â |
   Negative | 30 (54%) |
   Positive | 26 (46%) |
American Joint Committee on Cancer Stage | Â |
   I | 24 (43%) |
   II | 16 (29%) |
   III | 14 (25%) |
   IV | 2 (4%) |
Grade | Â |
   1 | 19 (34%) |
   2 | 18 (32%) |
   3 | 19 (34%) |
ER status | Â |
   Negative | 7 (13%) |
   Positive | 48 (86%) |
   Unknown | 1 (1%) |
PR status | Â |
   Negative | 17 (30%) |
   Positive | 39 (70%) |
P53 status | Â |
   Negative | 40 (71%) |
   Positive | 14 (25%) |
   Unknown | 2 (4%) |
HER2 status | Â |
   Negative | 41 (73%) |
   Positive | 15 (27%) |